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Castleman disease is an uncommon benign lymphoproliferative disorder characterized by hypervascular lymphoid hyperplasia. 1, 2 Approximately 75% of all cases are found in the mediastinum; 15% are found in the abdomen, retroperitoneum, or pelvis; and 10% occur in the head and neck. A few isolated cases have also been described in extralymphatic tissues, including the lung, larynx, parotid gland, pancreas, and muscle. 3, 4 The etiology of Castleman disease is unclear, but it is believed to be inflammatory or hamartomatous in nature.
We evaluated 2 patients with Castleman disease of the neck. Patient 1 was a 49-year-old woman who presented with a 3-year history of an anterior neck mass and a complaint of fatigue. She denied weight loss, fe-ver, chills, night sweats, abdominal pain, and bleeding. Her medical history was significant for hypothyroidism, which was well controlled with thyroid hormone replacement therapy. Physical examination revealed that the area of her lower neck was enlarged with no tenderness to palpation. Contrast-enhanced computed tomography (CT) demonstrated a well-marginated, nonenhancing, solid mass in the anterior portion of the lower neck; no evidence of lymphadenopathy was seen ( figure 1 ). An excisional biopsy demonstrated hypervascular lymphoid hyperplasia, which yielded a diagnosis of Castleman disease of the hyaline vascular type.
Patient 2 was a 35-year-old woman with a nontender, right parapharyngeal mass with no evidence of IMAGING CLINIC Castleman disease exists in two distinct histologic variants-the hyaline vascular type and the plasma cell type. The hyaline vascular type is much more common, accounting for approximately 90% of cases. Histologically, this subtype is identifiable by the presence of small lymphoreticular follicles distributed within a hyalinized stroma ( figure 3 ). The plasma cell type is distinguished by the presence of larger lymphoreticular nodules separated by sheets of plasma cells and by a less vascular stroma. 2 Castleman disease can also be categorized as either unicentric or multicentric. Typically, the unicentric variety is of the hyaline vascular type and is amenable to surgical treatment. The multicentric variety is often of the plasma cell type, which is associated with systemic manifestations. 3, 4 Castleman disease can occur at any age, but its peak incidence occurs in the third and fourth decades of life; the multicentric form usually affects older individuals. 3 Patients with the hyaline vascular variant tend to be asymptomatic, although some have complained of symptoms caused by compression of adjacent structures, and others have reported a palpable mass. Approximately 50% of patients with the plasma cell variant experience systemic manifestations, including fever, anemia, and hyperglobulinemia. 2 The treatment of the hyaline vascular type in the head and neck is surgical resection; the prognosis is good, and recurrence is not common. Patients with the plasma cell type usually undergo chemoradiation with or without surgical resection, but despite treatment, their prognosis is poor. 5 
